Faron Pharmaceuticals Oy (LON:FARN) Shares Pass Below Fifty Day Moving Average – Should You Sell?

Faron Pharmaceuticals Oy (LON:FARN) crossed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of GBX 42.87 and traded as low as GBX 40. Faron Pharmaceuticals Oy shares last traded at GBX 40.08, with a volume of 45,991 shares trading hands.

Faron Pharmaceuticals Oy Stock Down 4.6%

The company has a debt-to-equity ratio of -133.35, a current ratio of 0.84 and a quick ratio of 1.09. The stock has a market capitalization of £81.31 million, a P/E ratio of -1.82 and a beta of 1.12. The firm has a 50 day moving average of GBX 42.87 and a 200-day moving average of GBX 76.03.

Faron Pharmaceuticals Oy Company Profile

Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.